title: Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation.
authors.affiliation: Liver Unit, Division of Medicine, Jerusalem, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Israeli
authors.forename: E
authors.initials: E
authors.lastname: Galun
authors.forename: A
authors.initials: A
authors.lastname: Eid
authors.forename: Y
authors.initials: Y
authors.lastname: Ilan
authors.forename: Y
authors.initials: Y
authors.lastname: Ashur
authors.forename: O
authors.initials: O
authors.lastname: Jurim
authors.forename: A
authors.initials: A
authors.lastname: Bishara
authors.forename: R
authors.initials: R
authors.lastname: Safadi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000188:drug therapy; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin